Download PDF
Exp Clin Endocrinol Diabetes 2023; 131(03): 142-152
DOI: 10.1055/a-1944-2686
Article

Serum Uromodulin in Children and Adolescents with Type 1 Diabetes Mellitus and Controls: Its Potential Role in Kidney Health

Ralf Schiel
1   MEDIGREIF-Inselklinik Heringsdorf GmbH, Department of Diabetes and Metabolic Diseases, Ostseebad Heringsdorf, Germany
,
Mathias Block
2   Euroimmun Medizinische Labordiagnostika AG, Lübeck, Germany
,
Antje Steveling
3   University of Greifswald, School of Medicine, Internal Medicine A, Greifswald, Germany
,
Günter Stein
4   Friedrich-Schiller-University, School of Medicine, Internal Medicine, Nephrology, Jena, Germany
,
Sarah Lücking
1   MEDIGREIF-Inselklinik Heringsdorf GmbH, Department of Diabetes and Metabolic Diseases, Ostseebad Heringsdorf, Germany
,
Jürgen Scherberich
5   Klinikum München-Harlaching, München-Klinik, Teaching Hospital of The Ludwig-Maximilians University, München
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Introduction Uromodulin is a kidney-specific tubular protein, and its assessment in serum (sUMOD) reveals the potential as a novel marker for function and the integrity of renal parenchymal cells and does not directly depend on the glomerular filtration rate. Early diabetic nephropathy parallels glomerular hyperfiltration, often leading to diagnostic misinterpretation. Moreover, traditional kidney function markers are not able to diagnose structural lesions. Recent data show that sUMOD is linked to glucose intolerance in adults. Thus, we launched to assess the hypothesis that sUMOD is also associated with kidney function, biometric data, and quality of metabolic control in children/adolescents with type 1 diabetes.

Patients and methods Patients with type 1 diabetes (n=135) and healthy controls (n=69) were recruited to participate in the trial. Clinical, biometrical data, sUMOD, and other laboratory parameters were assessed.

Results The mean concentrations of sUMOD in diabetic patients and controls were comparable (201.19±103.22 vs. 198.32±84.27 ng/mL, p=0.832). However, in contrast to healthy controls, sUMOD levels in patients with diabetes were associated with serum-creatinine (r=−0.368, p<0.0001), age (r=−0.350, p<0.0001), height (r=−0.379, p<0.0001), body weight (r=−0.394, p<0.0001), Body mass index (r=−0.292, p=0.001), daily insulin dosage (r=−0.300, p<0.0001), HbA1c (%) (r=−0.190, p=0.027), standardized HbA1c/IFCC (mmol/mol) (r=−0.189, p=0.028), and systolic (r=−0.299, p<0.0001) and diastolic (r=−0.235, p=0.006) arterial blood pressure.

Conclusions Our study shows that children/adolescents with type 1 diabetes disclose similar sUMOD concentrations as healthy controls. Serum UMOD appears to indicate higher risks for kidney tissue remodeling and possibly subsequent cardiovascular alterations. However, further studies are mandatory to settle these findings.

Key words

Serum uromodulin - ELISA - kidney biomarker - juvenile type 1 diabetes - risk assessment


Publication History

Received: 08 April 2021
Received: 05 August 2022

Accepted: 14 September 2022

Accepted Manuscript online:
14 September 2022

Article published online:
13 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Jepson C, Hsu JY, Fischer MJ. et al. Incident type 2 diabetes among individuals with CKD: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2019; 73: 72-81 DOI: 10.1053/j.ajkd.2018.06.017.
    CrossrefPubMedGoogle Scholar
  • 2 Thomas MC, Cooper ME, Zimmet P.. Changing epidemiology of type 2 diabetes mellitus and associated kidney disease. Nat Rev Nephrol 2016; 12: 73-81 DOI: 10.1038/nrneph.2015.173.
    CrossrefPubMedGoogle Scholar
  • 3 Koye DN, Magliano DJ, Nelson RG. et al. The global epidemiology of diabetes and kidney disease. Adv Chronic Kidney Dis 2018; 25: 121-132 DOI: 10.1053/jackd.2017.10.011.
    CrossrefPubMedGoogle Scholar
  • 4 Frei U, Schober-Halstenberg HJ.. Nierenersatztherapie in Deutschland. Bericht über dialysebehandlung und nierentransplantation in Deutschland 2006/2007. Berlin: QuaSi-Niere; 2008
    Google Scholar
  • 5 Merker M, Bautsch BW, Ebert T. et al. Nephropathie bei diabetes. Diabetologie 2019; 14: S235-S239
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Umanath K, Lewis JB.. Update on diabetic nephropathy: Core Curriculum 2018. Am Kidney Dis 2018; 71: 884-895 DOI: 10.1053/j.ajkd.2017.10.026.
    CrossrefPubMedGoogle Scholar
  • 7 Magagnotti C, Zerbini G, Fermo I. et al. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes. J Proteomics 2019; 193: 205-216 DOI: 10.1016/j.jprot.2018.10.010.
    CrossrefPubMedGoogle Scholar
  • 8 Raja P, Maxwell AP, Brazil DP.. The potential of albuminuria as a biomarker of diabetic complications. Cardiovasc Drugs Ther 2020; DOI: 10.1007/s10557-020-07035-4.
    CrossrefPubMedGoogle Scholar
  • 9 Kaplan B, Schold J, Meier-Krische H-L.. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 2003; 3: 1560-1566
    CrossrefPubMedGoogle Scholar
  • 10 Delanaye P, Cavalier E, Pottel H.. Serum creatinine: Not so simple!. Nephron 2017; 136: 302-308
    CrossrefPubMedGoogle Scholar
  • 11 Knight EL, Verhave JC, Spiegelman D. et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421
    CrossrefPubMedGoogle Scholar
  • 12 Brezis M, Rosen S.. Hypoxia of the renal medulla – its implications for disease. N Engl J Med 1995; 332: 647-655
    CrossrefPubMedGoogle Scholar
  • 13 Heyman SN, Rosenberger C, Rosen S.. Experimental ischemia–reperfusion: Biases and myths – the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int 2010; 77: 9-16
    CrossrefPubMedGoogle Scholar
  • 14 Devuyst O, Olinger E, Rampoldi L.. Uromodulin: From physiology to rare and complex kidney disorders. Nat Rev Nephrol 2017; 13: 525-544
    CrossrefPubMedGoogle Scholar
  • 15 Schaeffer C, Devuyst O, Rampoldi L.. Uromodulin: Roles in health and disease. Ann Rev Physiol 2021; 83: 477-501
    CrossrefPubMedGoogle Scholar
  • 16 Alesutan I, Luong TTD, Schelski N. et al. Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signaling. Cardiovasc Res 2021; 117: 930-941
    CrossrefPubMedGoogle Scholar
  • 17 Mo L, Huang HY, Zhu XH. et al. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int 2004; 66: 1159-1166
    CrossrefPubMedGoogle Scholar
  • 18 Tokonami N, Takata T, Beyeler J. et al. Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC. Kidney Int 2018; 94: 701-715 DOI: 10.1016/j.kint.2018.04.021.
    CrossrefPubMedGoogle Scholar
  • 19 Boder P, Mary S, Mark PB. et al. Mechanistic interactions of uromodulin with thick ascending limb: perspectives in physiology and hypertension. J Hypertens 2021; 39: 1490-1504
    CrossrefPubMedGoogle Scholar
  • 20 LaFavers KA, Macedo E, Garimella PS. et al. Circulating uromodulin inhibits systemic oxidative stress by inactivating the TRPM2 channel. Sci Transl Med 2019; 11: eaaw3639 DOI: 10.1126/scitranslmed.aaw3639.
    CrossrefPubMedGoogle Scholar
  • 21 Scherberich JE, Gruber R, Nockher WA. et al. Serum uromodulin – A marker of kidney function and renal parenchymal integrity. Nephrol Dial Transplant 2018; 33: 284-295 DOI: 10.1093/ndt/gfw422.
    CrossrefPubMedGoogle Scholar
  • 22 Steubl D, Block M, Herbst V. et al. Urinary uromodulin independently predicts end-stage renal disease and rapid kindney function decline in a cohort of chronic kidney disease patients. Medicine 2019; 98: 21 (e15808) DOI: 10.1097/MD.0000000000015808.
    CrossrefPubMedGoogle Scholar
  • 23 Leiherer A, Muendlein A, Saely CH. et al. The value of uromodulin as a new serum marker to predict decline in renal function. J Hypertens 2018; 36: 110-118 DOI: 10.1097/HJH.0000000000001527.
    CrossrefPubMedGoogle Scholar
  • 24 Scherberich JE, Wolf G, Albers C. et al. Glomerular and tubular membrane antigens reflecting cellular adaptation in human renal failure. Kidney Int 1989; 36: S18-S51
    PubMedGoogle Scholar
  • 25 Risch L, Lhotta K, Meier D. et al. The serum uromodulin level is associated with kidney function. Clin Chem Lab Med 2014; 52: 1755-1761
    PubMedGoogle Scholar
  • 26 Then C, Then HL, Lechner A. et al. Serum uromodulin and decline of kidney function in older participants of the population-based KORA F4/FF4 study. Clin Kidney J 2021; 14: 205-211 DOI: 10.1093/ckj/sfaa032.
    CrossrefPubMedGoogle Scholar
  • 27 Scheurlen KM, Billeter AT, Kopf S. et al. Serum uromodulin and Roux-en-Y gastric bypass: Improvement of a marker reflecting nephron mass. Surg Obes Relat Dis 2019; 15: 1319-1325
    CrossrefPubMedGoogle Scholar
  • 28 Cosentino F, Grant PJ, Aboyans V. et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41: 255-323 DOI: 10.1093/eurheartj/ehz486.
    CrossrefPubMedGoogle Scholar
  • 29 Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA). Leitlinien. Verabschiedet auf der Konsensus-Konferenz der AGA am 10.09.04. HYPERLINK "http://www.a-g-a.de/" \t "_parent" http://www.a-g-a.de, 04.04.2013
    PubMed
  • 30 Williams B, Mancia G, Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021-3104 DOI: 10.1093/eurheartj/ehy339.
    CrossrefPubMedGoogle Scholar
  • 31 Meixner K, Glattacker M, Gerdes N. et al. Effects of treatment in mother-child rehabilitation centres. Rehabilitation (Stuttgart) 2001; 40: 280-288
    PubMedGoogle Scholar
  • 32 The Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
    CrossrefPubMedGoogle Scholar
  • 33 International Society of Nephrology 2012. International Society of Nephrology. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3. http://www.kidney-international.org, 03.04.2020
    PubMed
  • 34 Enko D, Meinitzer A, Scherberich JE. et al. Individual uromodulin serum concentration is independent of glomerular filtration rate in healthy kidney donors. Clin Chem Lab Med 2020; 59: 563-570 DOI: 10.1515/cclm-2020-0894.
    CrossrefPubMedGoogle Scholar
  • 35 El-Achkar TM, McCracken R, Rauchman M. et al. Tamm-Horsfall protein-deficient thick ascending limbs promote injury to neighboring S3 segments in an MIP-2-dependent mechanism. Am J Physiol Renal Physiol 2011; 300: F999-F1007
    CrossrefPubMedGoogle Scholar
  • 36 Tan RJ, Li Y, Rush BM. et al. Tubular injury triggers podocyte dysfunction by ß-catenin-driven release of MMP-7. JCI Insight 2019; 4: e122399
    CrossrefPubMedGoogle Scholar
  • 37 Wiromrat P, Bjornstad P, Roncal C. et al. Serum uromodulin inversely associates with aortic stiffness in youth with type 1 diabetes: A brief report from EMERALD study. J Diabetes Complications 2019; 33: 434-436 DOI: 10.1016/jdiacomp.2019.03.001.
    CrossrefPubMedGoogle Scholar
  • 38 Van JAD, Clotet-Freixas S, Zhou J. et al. Peptidomic analysis of urine from youths with early type 1 diabetes reveals novel bioactivity of uromodulin peptides in vitro. Mol Cell Proteomics 2020; 19: 501-517 DOI: 10.1074/mcp.RA119.001858.
    CrossrefPubMedGoogle Scholar
  • 39 Then C, Then H, Meisingerr C. et al. Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4/FF4 study participants. J Clin Endocrinol Metab 2019; jc.2018-02557 DOI: 10.1210/jc.2018-02557.
    CrossrefPubMedGoogle Scholar
  • 40 Youhanna S, Weber J, Beaujean V. et al. Determination of uromodulin in human urine: Influence of storage and processing. Nephrol Dial Transplant 2014; 29: 136-145
    CrossrefPubMedGoogle Scholar